CDKN2A and central nervous system cancer: We found the number of P16INK4A‐positive astrocytes increased dramatically, not only in mouse brains of the WBRT group, but also in recurrent glioma samples compared to paired primary samples (Figure 3C–E; Figure S3E,F,G, Supporting Information).